Literature DB >> 2032285

Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes.

W G Carter1, M C Ryan, P J Gahr.   

Abstract

Epiligrin is a new glycoprotein in most epithelial basement membranes (BMs) and is a ligand for cell adhesion via integrin alpha 3 beta 1. In the extracellular matrix of human foreskin keratinocytes (HFKs), epiligrin contains three disulfide-bonded, glycoprotein subunits, E170, E145, and E135, based on molecular size in kilodaltons. Epiligrin, immunopurified with MAb P1E1, induced cell adhesion and localization of integrin alpha 3 beta 1 in focal adhesions (FAs). Cell adhesion to epiligrin was inhibited with an anti-alpha 3 beta 1 MAb. Epiligrin also colocalized with integrin alpha 6 beta 4 in hemidesmosome-like stable anchoring contacts (SACs). alpha 3 beta 1-FAs encircled alpha 6 beta 4-SACs in a complex adhesion structure. alpha 3 beta 1 and epiligrin localized in BM junctions of epithelial cells primarily in organs of endodermal/ectodermal origin. In epidermis, epiligrin was detected in the lamina lucida of BMs. alpha 3 beta 1 localized in plasma membranes of basal cells in contact with epiligrin and also in lateral/apical membranes. Epiligrin is the ligand of an adhesion super complex composed of alpha 3 beta 1-FAs and alpha 6 beta 4-SACs (hemidesmosomes).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2032285     DOI: 10.1016/0092-8674(91)90092-d

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  162 in total

1.  Intestinal restitution: progression of actin cytoskeleton rearrangements and integrin function in a model of epithelial wound healing.

Authors:  M M Lotz; I Rabinovitz; A M Mercurio
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa.

Authors:  J E Kuster; M H Guarnieri; J G Ault; L Flaherty; P J Swiatek
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

3.  Forced expression of keratin 16 alters the adhesion, differentiation, and migration of mouse skin keratinocytes.

Authors:  M Wawersik; P A Coulombe
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 4.  Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases.

Authors:  J Uitto; A M Christiano
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Integrin gene expression profiles of human hepatocellular carcinoma.

Authors:  Lian-Xin Liu; Hong-Chi Jiang; Zhi-Hua Liu; Jing Zhou; Wei-Hui Zhang; An-Long Zhu; Xiu-Qin Wang; Min Wu
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  ZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cells.

Authors:  Justin M Drake; J Matthew Barnes; Joshua M Madsen; Frederick E Domann; Christopher S Stipp; Michael D Henry
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

7.  The role of a recombinant fragment of laminin-332 in integrin alpha3beta1-dependent cell binding, spreading and migration.

Authors:  Hironobu Yamashita; Manisha Tripathi; Mark P Harris; Shanshan Liu; Brandy Weidow; Roy Zent; Vito Quaranta
Journal:  Biomaterials       Date:  2010-03-27       Impact factor: 12.479

8.  Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes.

Authors:  John M Lamar; Vandana Iyer; C Michael DiPersio
Journal:  J Invest Dermatol       Date:  2007-08-30       Impact factor: 8.551

9.  Topical application of laminin-332 to diabetic mouse wounds.

Authors:  Stephen R Sullivan; Robert A Underwood; Randall O Sigle; Yuko Fukano; Lara A Muffley; Marcia L Usui; Nicole S Gibran; Marcos A Antezana; William G Carter; John E Olerud
Journal:  J Dermatol Sci       Date:  2007-08-24       Impact factor: 4.563

10.  Expression of epithelial adhesion proteins and integrins in chronic inflammation.

Authors:  K Haapasalmi; M Mäkelä; O Oksala; J Heino; K M Yamada; V J Uitto; H Larjava
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.